Alerts will be sent to your verified email
Verify EmailNORTHLINK
Northlink Fiscal
|
Samyak International
|
Rubra Medicaments
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
1.02 % | 1.23 % | -2.03 % |
5yr average Equity Multiplier
|
1.16 | 1.43 | 1.44 |
5yr Average Asset Turnover Ratio
|
0.4 | 0.4 | 1.44 |
5yr Avg Net Profit Margin
|
-0.58 % | 1.7 % | -0.31 % |
Price to Book
|
3.62 | 0.36 | 35.84 |
P/E
|
0.0 | 0.0 | 223.95 |
5yr Avg Cash Conversion Cycle
|
34.54 Days | -79.6 Days | 183.71 Days |
Inventory Days
|
0.87 Days | 82.16 Days | 0.0 |
Days Receivable
|
34.54 Days | 68.76 Days | 183.71 Days |
Days Payable
|
1.79 Days | 214.47 Days | 33.56 Days |
5yr Average Interest Coverage Ratio
|
4.91 | 2.64 | -248.31 |
5yr Avg ROCE
|
1.58 % | 2.62 % | -2.28 % |
5yr Avg Operating Profit Margin
|
14.6 % | 10.46 % | -0.3 % |
5 yr average Debt to Equity
|
0.07 | 0.17 | 0.06 |
5yr CAGR Net Profit
|
n/a | n/a | 0.0 |
5yr Average Return on Assets
|
0.89 % | 1.0 % | -1.63 % |
Shareholdings
|
|||
Promoter Holding
|
46.24 % | 22.35 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-10.96 % | 13.17 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Northlink Fiscal
|
Samyak International
|
Rubra Medicaments
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|